Clinical Trial Update: Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cardiac progenitor cell infusion for univentricular heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome
• Single Left Ventricle
• Single Right Ventricle

Snippet

Sponsor: Okayama University | Conditions: Hypoplastic Left Heart Syndrome, Single Right Ventricle | Phase 2 | Status: COMPLETED